These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19010273)

  • 1. Update on the management and therapeutic monitoring of advanced nasopharyngeal cancer.
    Loong HH; Ma BB; Chan AT
    Hematol Oncol Clin North Am; 2008 Dec; 22(6):1267-78, x. PubMed ID: 19010273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic treatment strategies and therapeutic monitoring for advanced nasopharyngeal carcinoma.
    Ma BB; Chan AT
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):383-94. PubMed ID: 16503855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in nasopharyngeal carcinoma.
    Guigay J
    Curr Opin Oncol; 2008 May; 20(3):264-9. PubMed ID: 18391624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a treatment paradigm also applicable to patients in Southeast Asia.
    Lu H; Peng L; Yuan X; Hao Y; Lu Z; Chen J; Cheng J; Deng S; Gu J; Pang Q; Qin J
    Cancer Treat Rev; 2009 Jun; 35(4):345-53. PubMed ID: 19211192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-targeted immunotherapy for nasopharyngeal carcinoma.
    Masmoudi A; Toumi N; Khanfir A; Kallel-Slimi L; Daoud J; Karray H; Frikha M
    Cancer Treat Rev; 2007 Oct; 33(6):499-505. PubMed ID: 17544585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Present status of management of nasopharyngeal carcinoma.
    Wei WI; Sham JS
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):134-41. PubMed ID: 12113121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment approaches to nasopharyngeal carcinoma: a review.
    Caponigro F; Longo F; Ionna F; Perri F
    Anticancer Drugs; 2010 Jun; 21(5):471-7. PubMed ID: 20124988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective cohort study of nasopharyngeal adenocarcinoma: a rare histological type of nasopharyngeal cancer.
    Guo ZM; Liu WW; He JH
    Clin Otolaryngol; 2009 Aug; 34(4):322-7. PubMed ID: 19673979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modern treatment for nasopharyngeal carcinoma: current status and prospects.
    Rottey S; Madani I; Deron P; Van Belle S
    Curr Opin Oncol; 2011 May; 23(3):254-8. PubMed ID: 21330921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A child with dermatomyositis and a suspicious lymphadenopathy.
    Martini G; Calabrese F; Biscaro F; Zulian F
    J Rheumatol; 2005 Apr; 32(4):744-6. PubMed ID: 15801035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasopharyngeal carcinoma. Biology, natural history, and therapeutic implications.
    Cvitkovic E; Bachouchi M; Armand JP
    Hematol Oncol Clin North Am; 1991 Aug; 5(4):821-38. PubMed ID: 1890068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging treatment options for nasopharyngeal carcinoma.
    Zhang L; Chen QY; Liu H; Tang LQ; Mai HQ
    Drug Des Devel Ther; 2013; 7():37-52. PubMed ID: 23403548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasopharyngeal carcinoma.
    Chen YP; Chan ATC; Le QT; Blanchard P; Sun Y; Ma J
    Lancet; 2019 Jul; 394(10192):64-80. PubMed ID: 31178151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments.
    Tao Q; Chan AT
    Expert Rev Mol Med; 2007 May; 9(12):1-24. PubMed ID: 17477889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
    Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of the transrenal excretion of circulating EBV DNA in nasopharyngeal carcinoma patients.
    Chan KC; Leung SF; Yeung SW; Chan AT; Lo YM
    Clin Cancer Res; 2008 Aug; 14(15):4809-13. PubMed ID: 18676752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dominance of China 1 in the spectrum of Epstein-Barr virus strains from Cantonese patients with nasopharyngeal carcinoma.
    Li DJ; Bei JX; Mai SJ; Xu JF; Chen LZ; Zhang RH; Yu XJ; Hong MH; Zeng YX; Kang T
    J Med Virol; 2009 Jul; 81(7):1253-60. PubMed ID: 19475622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of nasopharyngeal carcinoma.
    Jeyakumar A; Brickman TM; Jeyakumar A; Doerr T
    Ear Nose Throat J; 2006 Mar; 85(3):168-70, 172-3, 184. PubMed ID: 16615599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal management of nasopharyngeal carcinoma.
    Faivre S; Janot F; Armand JP
    Curr Opin Oncol; 2004 May; 16(3):231-5. PubMed ID: 15069318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viruses in head and neck cancers: prevention and therapy.
    Psyrri A; Burtness B
    Expert Rev Anticancer Ther; 2008 Sep; 8(9):1365-71. PubMed ID: 18759688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.